HEIDI CURTIS: Open Payments
NPI 1578958542 · GRIMES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,414 in 147 payments from 13 companies in 2025. Trend: 2023 $1,201 · 2024 $1,444 · 2025 $2,414
Food & beverage: $2,239Education: $175
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 44 | $806 |
| ABBVIE INC. | 36 | $547 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $192 |
| Galderma Laboratories, L.P. | 17 | $190 |
| Lilly USA, LLC | 7 | $156 |
| UCB, Inc. | 8 | $148 |
| PFIZER INC. | 10 | $144 |
| Organon LLC | 5 | $66 |
| Amgen Inc. | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
Products named: TREMFYA, SKYRIZI, NEMLUVIO, ILUMYA, Bimzelx, CIBINQO, TALTZ, RINVOQ.
Industry payments across IA — which companies pay providers there.
